{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,28]],"date-time":"2025-10-28T15:02:25Z","timestamp":1761663745838,"version":"3.41.0"},"reference-count":16,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"5","license":[{"start":{"date-parts":[[2018,5,1]],"date-time":"2018-05-01T00:00:00Z","timestamp":1525132800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"},{"start":{"date-parts":[[2018,6,5]],"date-time":"2018-06-05T00:00:00Z","timestamp":1528156800000},"content-version":"vor","delay-in-days":35,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Clinical Liver Disease"],"published-print":{"date-parts":[[2018,5]]},"DOI":"10.1002\/cld.702","type":"journal-article","created":{"date-parts":[[2018,6,6]],"date-time":"2018-06-06T14:22:56Z","timestamp":1528294976000},"page":"111-114","source":"Crossref","is-referenced-by-count":12,"title":["Hepatic fibrosis: Avenues of investigation and clinical implications"],"prefix":"10.1097","volume":"11","author":[{"given":"Jessica E.S.","family":"Shay","sequence":"first","affiliation":[{"name":"Osler Internal Medicine Residency Program,Johns Hopkins University School of Medicine,Baltimore,MD"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"James P.","family":"Hamilton","sequence":"additional","affiliation":[{"name":"Transplant Hepatology, Division of Gastroenterology and Hepatology,Johns Hopkins University School of Medicine,Baltimore,MD"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","published-online":{"date-parts":[[2018,6,5]]},"reference":[{"issue":"2","key":"cld702-bib-0001-20240115","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1172\/JCI24282","article-title":"Liver fibrosis","volume":"115","year":"2005","journal-title":"J Clin Invest"},{"issue":"2","key":"cld702-bib-0002-20240115","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1038\/ncpgasthep0055","article-title":"Mechanisms of disease: mechanisms of hepatic fibrosis and therapeutic implications","volume":"1","year":"2004","journal-title":"Nat Clin Pract Gastroenterol Hepatol"},{"issue":"9","key":"cld702-bib-0003-20240115","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1007\/s005350070045","article-title":"Hepatic stellate cells: a target for the treatment of liver fibrosis","volume":"35","year":"2000","journal-title":"J Gastroenterol"},{"issue":"5","key":"cld702-bib-0004-20240115","doi-asserted-by":"crossref","first-page":"1902","DOI":"10.1172\/JCI66369","article-title":"Hepatic stellate cells in liver development, regeneration, and cancer","volume":"123","year":"2013","journal-title":"J Clin Invest"},{"issue":"11","key":"cld702-bib-0005-20240115","doi-asserted-by":"crossref","first-page":"1728","DOI":"10.5858\/2007-131-1728-HSCALF","article-title":"Hepatic stellate cells and liver fibrosis","volume":"131","year":"2007","journal-title":"Arch Pathol Lab Med"},{"issue":"5","key":"cld702-bib-0006-20240115","doi-asserted-by":"crossref","first-page":"1887","DOI":"10.1172\/JCI66028","article-title":"Evolving therapies for liver fibrosis","volume":"123","year":"2013","journal-title":"J Clin Invest"},{"issue":"suppl 3","key":"cld702-bib-0007-20240115","first-page":"S84","article-title":"Hepatic stellate cells and the reversal of fibrosis","volume":"21","year":"2006","journal-title":"J Gastroenterol Hepatol"},{"issue":"3","key":"cld702-bib-0008-20240115","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1055\/s-2001-17558","article-title":"Hepatic stellate cells as a target for the treatment of liver fibrosis","volume":"21","year":"2001","journal-title":"Semin Liver Dis"},{"key":"cld702-bib-0009-20240115","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1080\/1061186X.2016.1262867","article-title":"Receptor\u2010specific TRAIL as a means to achieve targeted elimination of activated hepatic stellate cells","volume":"25","year":"2017","journal-title":"J Drug Target"},{"issue":"18","key":"cld702-bib-0010-20240115","doi-asserted-by":"crossref","first-page":"1675","DOI":"10.1056\/NEJMoa0907929","article-title":"Pioglitazone, vitamin E, or placebo for nonalcoholic steatohepatitis","volume":"362","year":"2010","journal-title":"N Engl J Med"},{"journal-title":"Hepatology","key":"cld702-bib-0011-20240115","article-title":"Therapeutic inhibition of inflammatory monocyte recruitment reduces steatohepatitis and liver fibrosis"},{"issue":"3","key":"cld702-bib-0012-20240115","doi-asserted-by":"crossref","first-page":"942","DOI":"10.1002\/hep.23419","article-title":"Reduction of advanced liver fibrosis by short\u2010term targeted delivery of an angiotensin receptor blocker to hepatic stellate cells in rats","volume":"51","year":"2010","journal-title":"Hepatology"},{"key":"cld702-bib-0013-20240115","first-page":"7629724","article-title":"Clinical advancements in the targeted therapies against liver fibrosis","volume":"2016","year":"2016","journal-title":"Mediators Inflamm"},{"issue":"4","key":"cld702-bib-0014-20240115","doi-asserted-by":"crossref","first-page":"G726","DOI":"10.1152\/ajpgi.00162.2009","article-title":"Effects of losartan on hepatic expression of nonphagocytic NADPH oxidase and fibrogenic genes in patients with chronic hepatitis C","volume":"297","year":"2009","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"issue":"9","key":"cld702-bib-0015-20240115","doi-asserted-by":"crossref","first-page":"1697","DOI":"10.1136\/gutjnl-2016-312473","article-title":"Selective targeting of lysyl oxidase\u2010like 2 (LOXL2) suppresses hepatic fibrosis progression and accelerates its reversal","volume":"66","year":"2017","journal-title":"Gut"},{"issue":"12","key":"cld702-bib-0016-20240115","doi-asserted-by":"crossref","first-page":"1783","DOI":"10.1111\/liv.13177","article-title":"Simtuzumab treatment of advanced liver fibrosis in HIV and HCV\u2010infected adults: results of a 6\u2010month open\u2010label safety trial","volume":"36","year":"2016","journal-title":"Liver Int"}],"container-title":["Clinical Liver Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1002%2Fcld.702","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.lww.com\/01979390-201805000-00002","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,7,5]],"date-time":"2025-07-05T00:36:36Z","timestamp":1751675796000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/01979390-201805000-00002"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,5]]},"references-count":16,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2018]]}},"URL":"https:\/\/doi.org\/10.1002\/cld.702","relation":{},"ISSN":["2046-2484","2046-2484"],"issn-type":[{"type":"print","value":"2046-2484"},{"type":"electronic","value":"2046-2484"}],"subject":[],"published":{"date-parts":[[2018,5]]}}}